Connor Dowling

Connor Dowling is the Founding Executive Director of the Daniel Offit Fund to Fight Glioblastoma. His career has been dedicated to translating cutting-edge life sciences and healthcare research into real-world impact through venture creation.

He previously served as Founding Chief Operating Officer of the Weill Cornell Medicine BioVenture eLab, a pioneering center for biomedical entrepreneurship. In this role, he collaborated with hundreds of scientists, clinicians, and investors to launch biomedical technologies and ventures. Following this, Connor worked with Dr. Raul Rabadan at Columbia University, commercializing innovations in meta-omics and biosecurity through their startup, GenoTwin. GenoTwin gained recognition from leading accelerators and investors, successfully bringing its technology to market.

Connor holds a Master’s in Global Business Administration from The Fletcher School at Tufts University and is an Aspen Institute Fellow.

His commitment to the Daniel Offit Fund to Fight Glioblastoma is deeply personal: he lost his mother to glioblastoma early in his career. Connor channels this dedication and vision into the Fund, honoring Dan Offit's legacy by advancing promising treatments, care, and support for those affected by glioblastoma.